1,051 results

1. pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH (AAV8)

   Viral Prep

   #203840-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH (#203840). In addition to the viral particles, you will also receive purified pAAV-hSyn-Kir2.1WT-2A-mScarlet-KASH plasmid DNA. hSyn-driven expression of Kir2.1 and mScarlet-KASH. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Ivo Spiegel

   Article

   Roethler et al Neuron. 2023 Jun 20:S0896-6273(23)00399-

   Tags

   mScarlett

   Available Since

   Oct. 8, 2025

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (AAV8)

   Viral Prep

   #228902-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine (#228902). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-HA-HCARD-P2A-mCitrine plasmid DNA. CAG-driven, Cre dependent expression of a peripherally restricted DREADD. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Article

   Kang et al Cell. 2024 Dec 26;187(26):7433-7449.e20.

   Promoter

   Chicken Beta Actin

   Tags

   mCitrine

   Available Since

   Oct. 8, 2025

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-CaMKIIa-Flpo (AAV8)

   Viral Prep

   #183535-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-Flpo (#183535). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-Flpo plasmid DNA. CamKIIa-driven expression of Flpo recombinase. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Karl Deisseroth

   Article

   Fan et al Cell. 2023 Feb 2;186(3):543-559.e19. doi

   Promoter

   CaMKII

   Available Since

   Oct. 8, 2025

   Availability

   Academic Institutions and Nonprofits only

4. pAAV_BiCHATe27_GCaMP6f (AAV PHP.eB)

   Viral Prep

   #213833-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Available Since

   Sept. 29, 2025

   Availability

   Academic Institutions and Nonprofits only

5. pAAV_BiCHATe27_GCaMP6f (AAV1)

   Viral Prep

   #213833-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV_BiCHATe27_GCaMP6f (#213833). In addition to the viral particles, you will also receive purified pAAV_BiCHATe27_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the cholinergic neuron-targeting enhancer E27. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Available Since

   Sept. 23, 2025

   Availability

   Academic Institutions and Nonprofits only

6. pAAV_BiPVe3_GCaMP6f (AAV1)

   Viral Prep

   #213943-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV_BiPVe3_GCaMP6f (#213943). In addition to the viral particles, you will also receive purified pAAV_BiPVe3_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the PV+ basket cell-targeting enhancer E3. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Available Since

   Sept. 23, 2025

   Availability

   Academic Institutions and Nonprofits only

7. pAAV_BiPVe3_ChR2_mCherry (AAV1)

   Viral Prep

   #213941-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV_BiPVe3_ChR2_mCherry (#213941). In addition to the viral particles, you will also receive purified pAAV_BiPVe3_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the PV+ basket cell-targeting enhancer E3. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Tags

   mCherry

   Available Since

   Sept. 23, 2025

   Availability

   Academic Institutions and Nonprofits only

8. pAAV_BiPVe4_GCaMP6f (AAV1)

   Viral Prep

   #213939-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV_BiPVe4_GCaMP6f (#213939). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Available Since

   Sept. 23, 2025

   Availability

   Academic Institutions and Nonprofits only

9. pAAV_BiPVe4_ChR2_mCherry (AAV1)

   Viral Prep

   #213937-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV_BiPVe4_ChR2_mCherry (#213937). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_ChR2_mCherry plasmid DNA. Expression of mCherry-tagged channelrhodopsin-2 under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Gordon Fishell

   Article

   Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

   Tags

   mCherry

   Available Since

   Sept. 23, 2025

   Availability

   Academic Institutions and Nonprofits only

10. pAAV_BiLAMP5e3_GCaMP6f (AAV1)

    Viral Prep

    #213917-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV_BiLAMP5e3_GCaMP6f (#213917). In addition to the viral particles, you will also receive purified pAAV_BiLAMP5e3_GCaMP6f plasmid DNA. Expression of GCaMP6f under the control of the Lamp5 interneuron-targeting enhancer E3. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Gordon Fishell

    Article

    Furlanis et al Neuron. 2025 May 21;113(10):1525-1547.e1

    Available Since

    Sept. 23, 2025

    Availability

    Academic Institutions and Nonprofits only